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A B S T R A C T   
Mycotoxin intoxication is in general an acknowledged and tackled issue in animals. However, in several parts of 
the world, mycotoxicoses in humans still remain a relevant issue. The efficacy of two mycotoxin detoxifying 
animal feed additives, an aflatoxin bentonite clay binder and a fumonisin esterase, was investigated in a human 
child gut model, i.e. the in vitro Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). Additionally, 
the effect of the detoxifiers on gut microbiota was examined in the SHIME. After an initial two weeks of system 
stabilisation, aflatoxin B1 (AFB1) and fumonisin B1 (FB1) were added to the SHIME diet during one week. Next, 
the two detoxifiers and mycotoxins were added to the system for an additional week. The AFB1, FB1, hydrolysed 
FB1 (HFB1), partially hydrolysed FB1a and FB1b concentrations were determined in SHIME samples using a 
validated ultra-performance liquid chromatography-tandem mass spectrometry method. The short-chain fatty 
acid (SCFA) concentrations were determined by a validated gas chromatography–mass spectrometry method. 
Colonic bacterial communities were analysed using metabarcoding, targeting the hypervariable V1-V3 regions of 
the 16S rRNA genes. The AFB1 and FB1 concentrations significantly decreased after the addition of the 
detoxifiers. Likewise, the concentration of HFB1 significantly increased. Concentrations of SCFAs remained 
generally stable throughout the experiment. No major changes in bacterial composition occurred during the 
experiment. The results demonstrate the promising effect of these detoxifiers in reducing AFB1 and FB1 con-
centrations in the human intestinal environment, without compromising the gastrointestinal microbiota.   
1. Introduction 
Food security and safety continue to be one of the world’s major 
challenges as Earth’s population is expected to grow by another 2 billion 
people and is projected to reach 9.7 billion by 2050, as reported by the 
United Nations (2019). However, the rapidly augmenting population is 
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not the only factor jeopardising food security. A universal concern for 
the safety of both food and feed is the presence of secondary fungal 
metabolites known as mycotoxins. Particularly in sub-Saharan Africa, 
where the highest prevalence of undernourishment prevails, cereal- 
based crops are spoiled by moulds and their toxins. Contamination 
with these toxicogenic fungi and their mycotoxins results in a decrease 
of the amount of edible food and feed as well as in acute and chronic 
mycotoxicoses (Bennett & Klich, 2003). 
Aflatoxins (AF) and fumonisins (FB) are mainly produced by Asper-
gillus flavus and A. parasiticus, and Fusarium verticillioides and 
F. proliferatum fungi, respectively, and can result in adverse health ef-
fects in both humans and animals (Zain, 2010). Moreover, the notable 
persistence and ubiquitous nature of these toxins in sub-Saharan Africa 
are associated with large economic consequences. Food and feed 
spoilage directly affects smallholder farmers and families leading to a 
loss in resources and income. Subsistence farming is widespread in Af-
rica and its produce is more prone to mycotoxin contamination 
(Matumba, Van Poucke, Ediage, & De Saeger, 2017). Above all, while 
food security remains a problem (FAO, 2020; FAO, IFAD, & WFP, 2013), 
food safety is less regulated (FAO, 2004), sporadically leading to fatal 
mycotoxicoses (Nduti, 2017). In addition, mycotoxin contamination 
limits trade of agricultural products from sub-Saharan Africa to the rest 
of the world (Mutegi et al., 2013; Udomkun et al., 2017). 
In Kenya, the exposure to aflatoxin B1 (AFB1) and fumonisin B1 
(FB1) through the staple diet such as maize and groundnuts, including 
their derived products, is especially imminent (Kemboi, Ochieng, et al., 
2020; Kibugu et al., 2019; Mutegi et al., 2013; Sirma et al., 2016; 
Udomkun et al., 2017; Wangia et al., 2019). Several outbreaks of afla-
toxicosis, resulting in a large number of human casualties, have been 
reported in recent years in Kenya (Probst, Njapau, & Cotty, 2007). 
During the 2004 outbreak, a total of 317 cases of acute hepatic failure 
were documented, including 125 deaths after consuming locally grown 
maize stored under poor conditions. However, these numbers are most 
likely severely underestimated as hospitals are not always accessible for 
everybody and transportation is not always evident (Azziz-baumgartner 
et al., 2005; CDC, 2004). Aflatoxin B1 is carcinogenic to humans (In-
ternational Agency for Research on Cancer - IARC Group 1), and is 
strongly correlated with liver cancer (IARC, 1993, 2002). Co- 
contamination of cereals with AFB1 and FB1 is of great concern 
(Mutiga, Hoffmann, Harvey, Milgroom, & Nelson, 2015). Fumonisin B1 
is possibly carcinogenic to humans and has been shown to cause oeso-
phageal cancer in laboratory animals (IARC Group 2B) (IARC, 1993). 
Chronic exposure to AF and FB has also been linked to stunting in 
children (Gong et al., 2002; IARC, 2015; WHO, 2018; Wild & Gong, 
2010). Children are more vulnerable than adults; they have a lower 
detoxification capacity, grow rapidly and have a high food intake per kg 
body weight. The metabolite AFM1 of AFB1 is excreted in milk, and is 
therefore an additional risk to child health (Kemboi, Antonissen, et al., 
2020; Kemboi, Ochieng, et al., 2020). Currently, Kenyans still consume 
grain and nut products exceeding the national set legal limits of myco-
toxins (Kibugu et al., 2019). Action must be urgently taken to further 
prevent mycotoxin outbreaks. 
To reduce mycotoxin exposure to humans, both pre- and post-harvest 
strategies are equally important. Both need to be implemented collec-
tively to prevent mycotoxicoses. Pre-harvest techniques are required in 
the field. These strategies include optimal planting density, crop rota-
tion, tillage, plant stressor management and chemical control (Rose 
et al., 2018). Post-harvest techniques are of importance during the pre- 
consumption phase. These strategies include optimal storage manage-
ment, with optimal temperature, moisture level, humidity, sorting, 
dehulling and separation of spoiled grains. During food processing, 
nixtamalisation and fermentation are promising mitigation strategies 
(Luo, Liu, & Li, 2018; Odukoya et al., 2021). 
Mycotoxin detoxifiers, such as binders and modifiers, are frequently 
applied as animal feed additives to prevent acute and chronic mycotoxin 
toxicity (Dell’Orto, Baldi, & Cheli, 2015). Two specific detoxifiers, a 
bentonite clay binder and a fumonisin esterase, have been approved by 
the European Food Safety Authority as feed additives (FEEDAP, 2011; 
FEEDAP et al., 2017). The AF binder, consisting of bentonite clay, binds 
AFB1 and other aflatoxins, hence reducing their availability for gastro-
intestinal absorption. The FB modifier consists of a purified enzyme that 
is specific for cleaving the FB side chains, resulting in the formation of 
less toxic FB metabolites (e.g. hydrolysed FB1 (HFB1) and partially 
hydrolysed FB1 (pHFB1a and pHFB1b) from the main analogue, FB1) in 
the gastrointestinal tract. The bentonite additive with identification 
code 1m558 (i.e. substance for the reduction of the contamination of 
feed by mycotoxins), has been approved for ruminants, poultry, and 
pigs, and the fumonisin esterase (1m03) for all poultry species and pigs 
(EC, 2020). Both products have been extensively tested in different types 
of in vitro and in vivo experimental studies and were found safe and 
effective in animals (FEEDAP, 2011; FEEDAP et al., 2017). On the 
contrary, in humans, little information is available on the consumption 
of these detoxifiers. Bentonite has been reported to adsorb some min-
erals and vitamins, such as Cu, Zn, Co, Mn and vitamin B6 in vitro 
(Tomasevic-Canovic, Dakovic, Markovic, Radosavljevic-mihajlovic, & 
Vukicevic, 2000). However, in animal trials, the effect of the same 
bentonite product adopted in this experiment was evaluated on the 
levels of vitamins in blood. No adverse effect of the binder was observed 
for vitamins such as A, D3, K, B1, B2, B6 and B12 in pigs after 7 days 
(Masching, Doupovec, & Schatzmayr, 2017), in chickens after 35 days 
(BIOMIN, 2014), and in dairy cattle after 7 days (Vetmeduni Wien, 
2018). Furthermore, in a 2-weeks and 3-months human trial, performed 
by Wang et al. (2005) in Texas and Afriyie-Gyawu et al. (2008) in Ghana, 
respectively, the safety of a similar clay was tested, and no effects on 
several minerals, including Cu, Zn and Mn, were observed, apart from an 
increase in Sr levels. Additionally, no bentonite-related differences were 
observed in haematology, liver and kidney functions and electrolytes. 
Furthermore, several studies reported by EFSA (FEEDAP, 2011) showed 
a decrease in heavy metal (Cd, Pb, Cs and Tl) uptake with the intake of 
bentonite. 
To the authors’ knowledge, no studies have been performed with the 
addition of detoxifiers to the Simulator of Human Intestinal Microbial 
Ecosystem (SHIME). In this respect, the SHIME is a promising in vitro 
technique to study the efficacy of such candidate detoxifiers as well as 
the effect of and on the microbiota. Biodegradation of ochratoxin A in a 
SHIME system has been studied (Ouethrani et al., 2013). A reduction in 
the beneficial species Lactobacillus reuteri was observed, and the 
descending colon was identified as being the main site of mycotoxin 
biodegradation. 
Therefore, the current study was performed to investigate the po-
tential detoxifying effect of an AF binder and a FB modifier in humans, 
with focus on children. Instead of using human beings, this study ben-
efits from the existence of the validated human gut model, to mimic the 
intestinal environment of a child. The goal of this study was to attain a 
post-harvest mitigation strategy, namely suitable detoxifiers that could 
be added to food in regions where contamination with AF and FB is a 
food safety problem, and where the availability of food is limited, such 
as sub-Saharan Africa. Furthermore, this study investigated the effect of 
the treatment on the gut microbiota. With this toddler SHIME system, 
the effect of both the AF binder and FB modifier on the mycotoxin 
concentrations and bacterial composition of the gut was investigated in 
vitro. Therefore, an analytical method to assess AFB1, FB1 as well as the 
FB1 hydrolysis products in SHIME medium samples was developed and 
validated. The impact of AFB1 and FB1 on the colonic microbiota was 
determined by measuring the short chain fatty acid (SCFA) production 
and by performing 16S metabarcoding analysis of bacterial population. 
Recording SCFA production is useful to monitor the colonisation and 
adaptation of the gut microbiota in the in vitro system during the sta-
bilisation period, and to study the effect of AFB1, FB1 and detoxifiers on 
human gut microbiota. 
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2. Materials and methods 
2.1. Mycotoxins, detoxifiers, reagents and materials 
Analytical AFB1 and FB1 standards, and BiopureTM 13C-labelled in-
ternal standards 13C17-AFB1 and 13C34-FB1 were purchased from Fer-
mentek (Jerusalem, Israel) and Romer Labs (Tulln, Austria), 
respectively. Analytical standards of pHFB1a, pHFB1b and HFB1, as well 
as the AFB1 binder, Mycofix® Secure (bentonite E558), and the FB1 
modifier, FUMzyme® (see Fig. S1 in supplementary materials), were 
obtained from Biomin® (Tulln and Getzersdorf, Austria). Aflatoxin B1 
stock and work solutions were prepared in acetonitrile (ACN) and stored 
at − 20 ◦C. Fumonisin B1 and metabolite solutions were prepared in 
water/ACN (50/50, v/v) and stored at 2–8 ◦C. Analytical grade formic 
acid, ACN, water and methanol, as well as glycerol and sodium bicar-
bonate (NaHCO3) were procured from VWR™ (Leuven, Belgium). Di- 
and tripotassium phosphate (K2HPO4 and K3PO4) were obtained from 
Chem-Lab NV (Zedelgem, Belgium) and hydrochloric acid (HCl) and 
sodium hydroxide (NaOH) from Sigma Aldrich BVBA (Overijse, 
Belgium). Formic acid, ammonium formate and ACN used for the 
preparation of mobile phases were of ULC–MS grade and were acquired 
from Biosolve (Valkenswaard, The Netherlands). Oasis® PRiME HLB 96- 
well plates (30 mg sorbent per well) and 96-well sample collection plates 
were from Waters™ (Antwerp, Belgium). 
2.2. Faecal inoculum 
The faeces used to inoculate the SHIME system were obtained from a 
2.3 years-old male child of African descent living in Merelbeke, Belgium, 
as several factors such as dietary habits, genetics and age have been 
shown to play a role in shaping the gut microbiome (David et al., 2014; 
Goodrich et al., 2016; Lim et al., 2014). The child’s diet reportedly 
consisted mainly of ugali, a typical African maize product, bread, Wee-
tabix® and spaghetti. The stool sample was collected, transported under 
cooled and anaerobic conditions, and processed upon arrival at the 
laboratory (<3 h). A 20% (m/m) suspension of the faecal sample in 
phosphate buffer was prepared. The mixture was homogenised and 
filtered in a stomacher bag with a mesh screen liner (80 µm pore size) 
(Biomérieux, Basingstoke, United Kingdom). An additional 20% of 
glycerol as cryoprotectant was added to the filtered substance. The 
sample was stored at − 80 ◦C until inoculation of the baby SHIME 
system. 
2.3. Experimental design and sample collection 
The toddler SHIME system consisted of five vessels in series, each in 
connection through tubes (Bondue, Lebrun, Taminiau, Everaert, 
LaPointe, Crèvecoeur, et al., 2020; Van Den Abbeele et al., 2010). Each 
vessel represented a different part of the gastrointestinal tract. The 
stomach in the first vessel was followed by a duodenum and ileum 
compartment, and the three parts of the colon; the ascending (AC), 
transverse (TC) and descending (DC). Each vessel had two chambers; an 
inner one holding the gastrointestinal contents and an outer one with 
circulating warm water at 37 ◦C. 
The growth medium used in the toddler SHIME (ref PD-NM005) was 
provided by ProDigest (Ghent, Belgium) in powder form, to be dissolved 
in water resulting in SHIME food for the system. Before connecting the 
feeding bottle to the SHIME system, the mixture was acidified with HCl 
(12 M) to obtain a pH of 3.8–4.0, corresponding to the pH of the stomach 
environment of a young child (Van Den Abbeele et al., 2010, 2012). The 
pancreatic juice was prepared by adding 2.5 g/L of NaHCO3, 4 g/L of 
bile salts (bovine) and 0.9 g/L of pancreatin (both provided by ProDi-
gest) to distilled, sterilised water and connected to the system. 
Furthermore, HCl (0.5 M) and NaOH (0.5 M) were connected to the 
colon compartments. Prior to the start-up of the experiment, 9, 14 and 
11 mL of faecal inoculum were added to the growth medium mixtures of 
150, 240 and 180 mL present in the AC, TC and DC compartments, 
respectively. In the colon compartments, stirrers rotated at 300 rpm 
continuously. The pH in the colon regions was automatically controlled 
through pH electrodes and maintained between 5.4–5.8, 6.0–6.3 and 
6.3–6.5 in the AC, TC and DC, respectively. 
After inoculation, the system was left to stabilise for two weeks, to 
allow the bacteria time to adapt to the new environment. This was fol-
lowed by the simultaneous addition of the two mycotoxins to 1 L of 
SHIME food for one week, i.e. AFB1 at a concentration of 81.6 µg/kg 
food and FB1 at a concentration of 2000 µg/kg food. Afterwards, the 
mycotoxins were added during another week, together with addition of 
the two detoxifiers (Mycofix® Secure − 2.5 g/kg food and FUMzyme® −
60 U/kg food). Food was pumped into the system three times a day (4 
mL/min during 10.5 min). 
Two repetitions were performed. An overview of the sampling days is 
presented in Fig. 1. SHIME samples were collected from AC, TC and DC 
on several days, i.e. one day after inoculation (day 1), immediately after 
the stabilisation period of 2 weeks (day 14 (T0)), during the first week 
with mycotoxins added (days 16, 19 and 21 (T1)) and during the second 
week with mycotoxins and detoxifiers added (days 23, 26 and 28 (T2)). 
A total of 12 mL was sampled from each colon compartment on each 
sampling occasion. All samples were stored at − 20 ◦C until further 
analyses. 
2.4. Mycotoxin analysis and method validation 
Based on a validated multi-mycotoxin UHPLC-MS/MS method for 
porcine plasma (Lauwers et al., 2019), the analytical protocol to quan-
tify the mycotoxins was adapted and fine-tuned for SHIME medium. 
Samples were centrifuged (10 min, 2851g, 4 ◦C) to remove AFB1- 
binder bound compounds before transferring 250 µL of supernatant to 
a falcon tube. Next, 25 µL of an internal standard solution containing 
100 ng/mL 13C17-FB1 and 10 ng/mL 13C34-AFB1 in ACN was added to 
the supernatant. The mixture was vortexed and allowed to equilibrate 
for 5 min at room temperature. Deproteinisation was performed by the 
addition of 700 µL of 0.1% formic acid in ACN and vortexing. Mixing 
occurred on a vertical rotating shaker (Trayster digital, IKA®, Staufen, 
Germany) during 10 min at 80 rpm. Samples were centrifuged (10 min, 
2851g, 4 ◦C) and supernatant was transferred to an Oasis PRiME HLB 96- 
well plate. The supernatant was allowed to slowly run through the 
sorbent before applying vacuum for 5 min. The eluate in the collector 
plate was dried under a nitrogen stream at 40 ◦C. The residue was 
reconstituted in 250 µL of water/methanol (50/50, v/v) and vortexed. 
The collector plate was placed into an autosampler and an aliquot of 5 µL 
was analysed by the UHPLC-MS/MS instrument (Acquity H-Class UPLC 
and Xevo® TQ-S MS, Waters, Milford, MA, USA). Mobile phase A was 
0.3% formic acid and 10 mM ammonium formate in water, and mobile 
phase B was ACN. Chromatographic separation was achieved using an 
Acquity HSS T3 column (2.1 × 100 mm, 1.8 µm particles; Waters), 
thermostatted at 45 ◦C. 
The LC-MS/MS method was validated for AFB1, FB1, pHFB1a, 
pHFB1b and HFB1 according to the protocol of De Baere et al. (2011). 
Blank SHIME medium, obtained after two weeks of stabilisation, was 
spiked with working solutions of AFB1, FB1, pHFB1a, pHFB1b and 
HFB1. The validation requirements complied with the guidelines 
established by the European Commission (2002). The following pa-
rameters were assessed: method linearity, within- and between-day ac-
curacy and precision, limit of detection (LOD) and of limit of 
quantification (LOQ), specificity, extraction recovery and matrix effect 
(signal suppression/enhancement). The results for each analyte are 
summarised in Tables S1 to S3. 
According to literature, AFB1 (<1–1000 µg/kg) and FB1 (<1–3000 
µg/kg) concentrations may be observed in a wide range in African crops 
(Creppy, 2002; Hove et al., 2016; Maringe et al., 2017; Rodrigues, 
Handl, & Binder, 2011; Sirma et al., 2016; Ssepuuya et al., 2018). Thus, 
AFB1 with a concentration of 81.6 µg/kg feed and FB1 with a 
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concentration of 2000 µg/kg feed were employed in the experiment to 
mimic high contaminations found under African circumstances. 
2.5. Short-chain fatty acid analysis 
The SCFA analysis was performed following the validated method for 
SHIME samples by Douny et al. (2019). To a 25 µL SHIME sample, 40 µL 
of 0.2 mg/mL methyl-valeric acid in water was added as internal stan-
dard, followed by the addition of 15 µL of 0.9 M H2SO4 in water and 920 
µL of fresh SHIME medium to obtain 1 mL. This solution was then vor-
texed and analysed by solid phase micro extraction gas chromatography 
coupled to mass spectrometry (Thermo Fisher Scientific, Massachusetts, 
USA). 
2.6. Metagenetic analysis – microbial community analysis 
The metagenetic analysis or marker gene amplification of the mi-
crobial V1-V3 regions of 16S rRNA was performed following the 
guidelines for 16S metagenomic sequencing library preparation for 
Illumina® technology users (Illumina, 2013) and the method described 
by Bondue, Lebrun, Taminiau, Everaert, LaPointe, Hendrick, & et al. 
(2020). Microbial DNA was extracted from the pellet of SHIME samples 
using the PSP® Spin Stool DNA Plus Kit (Invitek, Berlin, Germany). The 
V1-V3 regions of 16S rRNA genes were amplified through PCR with the 
forward 5′-GAGAGTTTGATYMTGGCTCAG-3′ and reverse 5′- 
ACCGCGGCTGCTGGCAC-3′ primers. Clean-up and purification of the 
PCR products using the Agencourt AMPure XP beads kit (Beckman 
Coulter, Pasadena, CA, USA) was followed by a second round of PCR 
using the Nextera XT Index Kit, followed by purification. PCR products 
were quantified with Quant-IT PicoGreen (ThermoFisher Scientific, 
Waltham, MA, USA) followed by normalisation, pooling and MiSeq 
sequencing using V3 reagents (Illumina, San Diego, CA, USA). Process-
ing of sequence reads was carried out as described previously (Bondue, 
Lebrun, Taminiau, Everaert, LaPointe, Hendrick, & et al., 2020). The 
obtained operational taxonomic units (OTUs) were used for the inversed 
Simpson diversity index calculation. 
2.7. Statistical analysis 
All statistical analyses for mycotoxin concentration, SCFA concen-
tration and metagenetic analysis data were performed using the soft-
ware package RStudio (R Core Team, 2020). Additionally, statistical 
analysis regarding the alpha diversity between colon regions, using the 
inversed Simpson diversity index, was evaluated using AMOVA in 
Mothur (Schloss et al., 2009). 
Data from the three colon regions were analysed separately. In 
addition, SCFA concentrations of the three colon regions were summed 
to represent the gastrointestinal tract (GIT). For the metagenetic anal-
ysis, significant differences between the three colon regions were addi-
tionally explored. 
Mycotoxin and SCFA concentration means of the three treatments 
and beta diversity were compared using a one-way ANOVA, provided 
the assumptions were met. Individual treatment means were then 
compared using Tukey’s HSD test. Normality of the residuals was tested 
with the Shapiro-Wilk test, followed by a Levene’s test for homosce-
dasticity. In case the residuals were not normally distributed, the non- 
parametric Kruskal-Wallis Rank Sum Test was performed, followed by 
the Pairwise Wilcoxon Rank Sum Test. In case the assumption of ho-
moscedasticity was not met, a Welch’s ANOVA was performed. The level 
of significance was set at 0.05. 
3. Results and discussion 
3.1. Mycotoxin analysis 
The SHIME samples collected before mycotoxin inoculation (day 1 
and 14, Fig. 1) contained traces of FB1 in all three colon regions of both 
repetitions, as shown in Fig. 2. A mean (±standard deviation, SD) FB1 
concentration of 2.93 ± 0.72 µg/kg and 0.93 ± 0.11 µg/kg (<LOQ of 1.0 
µg/kg) was found in the day 1 and 14 samples, respectively. This finding 
could possibly be explained by the origin of the faecal inoculum or from 
the growth medium. The toddler consumed wheat- and maize-based 
products on a daily basis. Fumonisins have been found in these partic-
ular foodstuffs in Europe (Stanciu et al., 2015), although the levels found 
are mostly low. Based on international data from 2002, the estimated 
mean FB1 uptake in Europe was 0.2 µg/kg body weight per day (Creppy, 
2002). In 2012, cereal samples collected in Northern Europe had levels 
for FB1 below the LOD of 100 µg/kg sample (Van Der Fels-Klerx et al., 
2012). 
A clear effect of the enzyme was notable since the FB1 concentrations 
(±SD) were significantly reduced from 872 ± 413 µg/kg on day 21 to 
299 ± 271 µg/kg (p = 0.025) on day 23, 18.8 ± 20.4 µg/kg (p < 0.01) on 
day 26 and 5.47 ± 2.57 µg/kg (p < 0.01) on day 28. This corresponds to 
a reduction in mean FB1 concentration by 65.0 ± 25.7%, 97.3 ± 3.1% 
and 99.1 ± 0.7%, respectively. The cumulative increase in FB1 con-
centration from day 16 to 21 was due to the fact that FB1 was added to 
the food and subsequently pumped through the system three times per 
day. 
In pig studies, the effect of the enzyme has previously been demon-
strated by measuring FB1 concentrations and associated biomarkers 
(sphinganine to sphingosine (Sa/So) ratio, and hydrolysed FB1 de-
rivatives) in serum, urine and faeces (Masching et al., 2016). A reduction 
of the FB1 concentration of about 50% and more than 90% was observed 
in pig faeces 7 days after addition of the enzyme with a dose of 15 and 
150 U/kg feed, respectively (Schwartz-Zimmermann et al., 2018). 
Masching et al. (2016) performed three experiments to determine the 
FB1 degrading potential of the same esterase. First, within two hours, 
the enzyme degraded FB1 completely into HFB1 in both jejunum and 
duodenum segments collected from a pig. Second, a decrease of 
approximately 46% and of 77% in FB1 was observed in the excreta of 
turkeys after 7 and 14 days, respectively (Masching et al., 2016). Third, 
in a pig trial, an average decrease of 72% in FB1 concentration in faeces 
Fig. 1. Timeline presenting the course of the experiment and the sampling days used for determination of mycotoxin concentration, short chain fatty acid con-
centration and metagenetic analysis. T0 = after two weeks of stabilisation and before addition of mycotoxins; T1 = after one week of addition of aflatoxin B1 (AFB1) 
(81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/kg food); T2 = after one week of addition of AFB1 (81.6 µg/kg food) and FB1 (2000 µg/kg food) with bentonite 
clay – Mycofix® Secure (2.5 g/kg food) and fumonisin esterase – FUMzyme® (60 U/kg food). 
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was observed after 14, 28 and 42 days of feeding the piglets fumonisins 
(2000 µg/kg) and fumonisin esterase (60 U/kg) (Masching et al., 2016). 
Even though the SHIME system is a more complex multi-compartmental 
system, nearly 100% reduction was observed after 5 days (day 26), 
therefore inducing a higher FB1 reduction compared to the in vivo 
studies from Masching et al. (2016). Considering that the SHIME is an in 
vitro model, human in vivo studies will have to be performed to verify the 
efficiency of this enzyme in the human gut. 
For HFB1, a significant increase in mean concentration was observed 
following addition of the detoxifiers (Fig. 3). The mean concentration of 
HFB1 (±SD) increased from 299 ± 145 µg/kg on day 23, to 563.6 ± 65.2 
µg/kg on day 26 and to 623.4 ± 71.0 µg/kg on day 28. 
In other studies, it was noticed that the natural degrading capacity of 
the gut microbiota might contribute to FB1 hydrolysis; the hydrolysed 
forms amounting up to about 50% on average of the total excreted 
fumonisins in faeces (Schertz et al., 2018; Schwartz-Zimmermann et al., 
2018). In this study, pHFB1a and pHFB1b were detected in samples 
before day 23 (Fig. S2). However, no HFB1 was detected earlier than on 
day 23 (LOD = 0.31 µg/kg), supporting the evidence that gut bacteria do 
contribute to partial FB1 hydrolysis. The observation of decreasing FB1 
concentrations (Fig. 2) and the concurrent increase of HFB1 concen-
trations (Fig. 3) following the addition of detoxifiers allowed us to 
conclude that the complete hydrolysis of FB1 into HFB1 in this experi-
ment may solely be ascribed to the effect of the enzyme. This is similar to 
the study performed in the ex vivo pig gastrointestinal model of 
Masching et al. (2016) where the degradation of FB1 by the enzyme 
resulted in an increase in HFB1, yet no pHFB1a nor pHFB1b were 
detected. These hydrolysis products have been proven to be far less toxic 
compared to the parent toxin in mice, pigs and rats. Grenier et al. (2012) 
found that FB1 induced hepatotoxicity and affected the intestinal 
integrity and immune response through inhibition of ceramide synthase, 
whilst HFB1 only slightly altered the intestinal immune response. 
Furthermore, Voss et al. (2009) observed that, in contrast to FB1, HFB1 
did not induce neural tube defects in unborn mice. In both studies, HFB1 
was also shown to only slightly disrupt the sphingolipid metabolism. 
Hahn et al. (2015) did not detect any differences in Sa/So ratio between 
rats being fed pHFB1a and pHFB1b during three weeks and the negative 
control group. Therefore, the results of this study seem promising in 
reducing, or even eliminating the toxic effects of FB1 in exposed 
humans. 
The AFB1 concentrations in the SHIME samples collected before 
mycotoxin inoculation were below the LOD of 0.002 µg/kg (Fig. 4). On 
day 1, in one DC sample of one repetition a trace amount of AFB1 was 
detected with a concentration of 0.330 µg/kg. The finding of a low AFB1 
concentration in a day 1 DC sample, and not in the AC nor TC, is most 
likely due to a contamination during sample processing and analysis in 
the laboratory. The cumulative increase in AFB1 concentration from day 
16 to 21 has the same explanation as FB1; AFB1 was added to the food 
and was from there on pumped through the system three times per day. 
When bentonite clay was administered together with the toxin, the 
AFB1 mean concentration ± SD significantly decreased about six-fold, i. 
e. from 24.60 ± 5.61 µg/kg on day 21 to 4.18 ± 4.35 µg/kg (p < 0.001) 
on day 23 (Fig. 4). A decrease of 78.9 ± 23.9% on day 23, 99.7 ± 0.5% 
on day 26 and 100% on day 28 in mean AFB1 concentration was 
observed, when compared to day 21. This is in accordance with the 
reported AFB1–binding capacity of minimum 90% of bentonite E558 
(EC, 2013b). Bentonite clay has been proven to be safe and effective, and 
authorised as feed additive in binding AFB1 in animals (ruminants, 
poultry and pigs) (EC, 2013a; FEEDAP, 2011); a decrease in AFM1 
excretion in milk of 55.0 to 68.0% and 17.3 to 21.3% was observed 
(Maki et al., 2017, 2016), and an in vitro study resulted in an AFB1 
adsorption capacity from 90.0% to 95.3% (FEEDAP et al., 2017). The 





















Fig. 2. Mean concentration of fumonisin B1 (FB1) determined in the AC, TC and DC compartment at different sampling days during the SHIME experiment (n = 2). 
Error bars represent the standard deviation. The dashed lines represent the addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and FB1 (2000 µg/kg food), followed by 
addition of both mycotoxins and bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food). The asterisks represent the significant statistical difference (*, 
p < 0.05 and **, p < 0.01) compared to sampling day 21. 
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effectiveness for detoxification in humans was determined by measuring 
AFM1 in urine and the AFB1-lysine adduct in serum (Awuor et al., 2017; 
Pollock et al., 2016; Wang et al., 2005). 
The adsorption of AFB1 to the binder in the GIT reduces the avail-
ability of AFB1 for absorption into the systemic circulation, hence 
reducing the oral bioavailability. Long-term in vivo studies will have to 
determine the effect of the binder in preventing further symptoms and 
diseases associated with acute and chronic AFB1 intoxications (Wang 
et al., 2008). Furthermore, additional data of long-term in vitro or in vivo 
studies are necessary to monitor the effect of binder uptake during 
longer periods on the vitamin and mineral status. 
3.2. Short-chain fatty acid (SCFA) analysis 
Concentrations of nine SCFAs were investigated to determine and 
monitor the gut health during the trial in both repetitions. A variety of 
metabolites are formed during the microbial fermentation and the main 
end-products are SCFAs. Therefore, surveying the SCFA production is 
valuable in monitoring colonisation and adjustment of the gut micro-
biota during the stabilisation period of the system, as well as in assessing 
the effect of the mycotoxins and detoxifiers on the gut microbiota during 
the experiment (Bernalier-Donadille, 2010). The most abundant SCFA 
produced were acetate, followed by propionate and butyrate. These act 
primarily as energy source for colonocytes, making them vital to overall 
gastrointestinal health (Demigne, Remesy, & Morand, 1999). Addi-
tionally, isobutyrate and isovalerate were measured in the SHIME 
samples. Although other fatty acids, such as valerate, caproate, enan-
thate and caprylate were also detected, their concentrations were found 
to be below the LOQ (48, 32, 32 and 32 mg/L, respectively). In all colon 
regions, the SCFA production was mostly similar in both repetitions. No 
significant differences were detected between the three treatments for 
individual SCFA concentrations in the AC, TC, DC (Fig. 5), nor in the GIT 
(Fig. S3). However, in DC, a decreasing trend in acetate was observed 
after administration of mycotoxins. 
In our study, the mean SCFA proportions of the stabilised bacteria 
followed an acetate/propionate/butyrate molar ratio of approximately 
71/20/9. Cinquin et al. (Cinquin, Le Blay, Fliss, & Lacroix, 2006) noticed 
a molar ratio of 75/19/6 in infant faeces and Cummings (1981) noted an 
average molar ratio of 60/24/16 in adult faeces. The SCFA ratio in our 
study approached the ratio found in infant faeces. The ratio in SCFA 
observed in the system at T0 in this study was comparable to other ex-
periments performed in the SHIME with faecal material from a child 
(<2y old) (Bondue, Lebrun, Taminiau, Everaert, LaPointe, Crèvecoeur, 
et al., 2020; Bondue, Lebrun, Taminiau, Everaert, LaPointe, Hendrick, & 
et al., 2020). 
Similar to the study of Bondue, Lebrun, Taminiau, Everaert, 
LaPointe, Hendrick, & et al. (2020), the SCFA concentration profile in 
the AC was evidently different from TC and DC (Fig. 5), while it was 
nearly identical in TC and DC. This corresponds to what is commonly 
seen in the microbial profile, discussed later on in Section 3.3.2. The 
lower pH in comparison to the TC and DC and availability of easily 
fermentable food in the AC will benefit some specific bacteria (mainly 
belonging to the phyla Firmicutes and Proteobacteria) that are readily 
able to consume these nutrients. 
A decreasing trend in acetate concentration from treatments T0 to T1 
in DC (p = 0.061) was observed (Fig. 5). However, no significant dif-
ference in acetate concentration was established between T1 and T2 (p 
= 0.62). Gut microbial fermentation, and thus acetate producing bac-
teria, such as Bifidobacteria, Lactobacillus, Akkermansia muciniphila, Pre-
votella and Ruminococcus (Venegas et al., 2019), could be affected by the 
addition of mycotoxins. Yet, this effect was not observed, and no addi-
tional effect by the addition of detoxifiers was observed. Possibly, the 
Fig. 3. Mean concentration of hydrolysed fumonisin B1 (HFB1) determined in the AC, TC and DC compartment at different sampling days during the SHIME 
experiment (n = 2). Error bars represent the standard deviation. The dashed lines represent the addition of aflatoxin B1 (81.6 µg/kg food) and fumonisin B1 (2000 
µg/kg food), followed by addition of both mycotoxins and bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food). The asterisks represent the sig-
nificant statistical difference (**, p < 0.01 and ***, p < 0.001) compared to sampling day 21. 
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slight decrease from T0 to T1 was due to natural fluctuations in time or 
method related variability. In the study of Zhou et al. (2018), the oral 
exposure of rats to 5, 25 and 75 µg AFB1/kg BW, resulted in a decrease of 
acetate, propionate and butyrate after 2 weeks onwards. Unfortunately, 
we implemented only one week of mycotoxin treatment. Our SHIME 
data are thus difficult to compare with these results. Acetate is formed by 
the decarboxylation of pyruvate by many bacterial groups present in the 
colon (Bernalier-Donadille, 2010; Louis, Hold, & Flint, 2014). Although 
all SCFAs play a role in regulating several organ systems, it has been 
demonstrated that acetate in particular plays an important role in en-
ergy generation and substrate metabolism (Hernández, Canfora, Jocken, 
& Blaak, 2019). 
Propionate concentrations were found to be rather similar in all three 
colon regions. It is mainly produced by Bacteroidetes spp., Firmicutes, 
Lachnospiraceae and Clostridium cluster IX (Cinquin et al., 2006; Reich-
ardt et al., 2014; Van Den Abbeele et al., 2010). 
Butyrate was produced in a smaller amount than acetate and pro-
pionate. However, we found higher butyrate concentrations in both the 
TC and DC compared to the AC. This was in accordance with another 
study using the toddler SHIME model (Bondue, Lebrun, Taminiau, 
Everaert, LaPointe, Hendrick, & et al., 2020). 
As for propionate, butyrate is produced by a restricted number of 
bacterial groups. Butyrate can be produced using two different path-
ways: the butyrate kinase pathway mainly used by Clostridium species 
and the butyryl-CoA:acetate-CoA transferase pathway that is preferred 
in presence of high acetate concentration (Louis et al., 2014). Therefore, 
the production of butyrate occurs in the distal part of intestinal micro-
biota, where acetate is high. The main butyrate producers are Faecali-
bacterium prausnitzii (Clostridium cluster IV), Anaerostipes, Eubacterium 
and Roseburia spp. (Clostridium cluster XIVa) (Rivière, Selak, Lantin, 
Leroy, & De Vuyst, 2016). As those bacteria are strictly anaerobic 
bacteria, butyrate can also be considered as an internal control of the 
anaerobiosis of the model. Butyrate concentrations remained stable 
throughout the repetitions, indicating anaerobic conditions were 
maintained in the system (Bondue, Lebrun, Taminiau, Everaert, 
LaPointe, Hendrick, & et al., 2020; Onrust et al., 2015). 
In general, the SCFA levels remained stable throughout the SHIME 
trial, indicating a healthy gut environment. The addition of solely the 
mycotoxins and in combination with detoxifiers did not negatively affect 
the SCFA producing capacity. 
3.3. Metagenetic analysis 
3.3.1. Alpha diversity 
The microbial gut community was assessed using 16S rRNA 
sequencing and diversity was determined from the obtained OTUs. No 
statistically significant differences in the inversed Simpson diversity 
index were observed on genus level in AC, TC, DC nor in the total GIT 
(Figs. S4-7) after administration of mycotoxins and detoxifiers to the 
SHIME system. This is in contrast to the study of Mateos et al. (2018), 
where six piglets were exposed to fumonisins (10.2 mg FB1, 2.5 mg FB2 
and 1.5 mg FB3/kg feed), and after 15 days of exposure the inversed 
Simpson index significantly decreased compared to the control. For 
AFB1, Yang et al. (2020) did not observe a significant difference in 
Simpson index between the control group and the group that received 
20 µg/kg or 500 µg/kg AFB1 via their diet during 2 months in turbots. 
Although no differences were observed between treatments within 
the colon regions, a significant difference (p < 0.001) in alpha diversity 
between the colon regions was determined (Fig. 6). Alpha diversity in 
AC was significantly lower than in both TC and DC (p < 0.01). Due to the 
lower pH and the availability of highly fermentable substrate in the AC, 
only a few specific populations were present, limiting the bacterial 
Fig. 4. Mean concentration of aflatoxin B1 (AFB1) determined in the AC, TC and DC compartment at the different sampling days during the SHIME experiment (n =
2). Error bars represent the standard deviation. The dashed lines represent the addition of AFB1 (81.6 µg/kg food) and fumonisin B1 (2000 µg/kg food), followed by 
addition of both mycotoxins and bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food). The asterisks represent the significant statistical difference (p 
< 0.001) compared to sampling day 21. 
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Fig. 5. Mean concentrations of short-chain fatty acids (SCFAs) in the a) ascending (AC), b) transverse (TC) and c) descending colon (DC) (n = 2). Error bars represent 
the standard deviation. Total is the sum of acetate, propionate, butyrate, isobutyrate and isovalerate. T0 = after two weeks of stabilisation and before addition of 
mycotoxins; T1 = after one week of addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/kg food); T2 = after one week of addition of 
AFB1 (81.6 µg/kg food) and FB1 (2000 µg/kg food), together with bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food). 
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diversity (Bondue, Lebrun, Taminiau, Everaert, LaPointe, Crèvecoeur, 
et al., 2020; Van Den Abbeele et al., 2010). AC was dominated by the 
genus Veillonella, whereas TC and DC are mainly composed of Lachno-
clostridium, Bacteroides and unidentified genera from the Lachnospir-
aceae family. 
3.3.2. Beta diversity 
Across all the phyla (Fig. 7), families (Fig. 8) and genera (Figs. 9 and 
10), no statistical significant differences in the relative abundance be-
tween the three treatments were found. 
The main phyla present in the faecal inoculum consisted of Firmi-
cutes (89.9%), Bacteroidetes (8.3%) and Proteobacteria (1.0%). These 
phyla were still present at T0, although at different proportions. On 
average, the bacterial population in AC constituted of Proteobacteria 
(64.1 ± 31.7%), Firmicutes (35.8 ± 31.6%) and Bacteroidetes (<0.1%). 
In TC and DC, Firmicutes (62.8 ± 2.6% and 72.1 ± 5.3%, respectively) 
were followed by Bacteroidetes (30.7 ± 0.1% and 22.4 ± 4.1%, 
respectively) and Proteobacteria (6.2 ± 2.7% and 5.1 ± 1.3%, respec-
tively). These relative abundances are similar to those found in pig 
faeces in the study of Mateos et al. (2018), where Firmicutes (82%) were 
most abundant, followed by Bacteroidetes (14%), Proteobacteria 
(1.8%), Spirochaetes (1.5%) and Actinobacteria (0.7%). Similarly, 
Grosu et al. (2019) found Firmicutes (58.3%), Bacteroidetes (34.5%), 
Proteobacteria (1.2%) and Spirochaetes and Actinobacteria (<0.01%) in 
the large intestines of piglets. At T1, in AC, Proteobacteria (54.2 ±
51.9%) remained present in the largest proportion, followed by Firmi-
cutes (45.7 ± 52.8%). In TC and DC, the latter were present in the 
highest abundance (56.8 ± 14.7% and 72.0 ± 10.8%, respectively) as 
well as Bacteroidetes (38.6 ± 12.1% and 21.9 ± 12.7%, respectively). 
Although no difference was observed in the SHIME, in the study of Grosu 
et al. (2019), after the addition of AFB1 to piglets’ diet during 30 days at 
320 µg/kg, Bacteroidetes (54.5%) statistically increased, whilst Firmi-
cutes (33.2%) decreased when compared to the control group. The 
duration of the SHIME trial might be the constraining factor. At T2, in 
AC, the proportion of Proteobacteria (98.2 ± 2.0%) dominated and 
Firmicutes (1.8 ± 1.9%) decreased. In TC and DC, the percentage of 
Firmicutes (61.0 ± 18.4% and 64.5 ± 14.4%, respectively) and Bacter-
oidetes (33.1 ± 15.4% and 29.6 ± 13.0%, respectively) remained stable. 
The phyla ratios present in each individual repetition per treatment can 
be seen in Fig. 7. 
Four major families analysed in the faecal inoculum were consec-
utively identified as Ruminococcaceae (42.7%), Lachnospiraceae (36.5%), 
Veillonellaceae (7.6%) and Prevotellaceae (6.6%). The first two families 
were also the main families found in the study of Bondue, Lebrun, 
Taminiau, Everaert, LaPointe, Hendrick, & et al. (2020). Similar to the 
families found in piglet faeces by Mateos et al. (2018), Lachnospiraceae, 
Ruminococcaceae and Prevotellaceae were found above 10% and Veillo-
nellaceae at 4.2%. Unlike in the latter study, no Lactobacillaceae were 
identified in the SHIME. At T0, in AC, mainly Enterobacteriaceae (63.6 ±
31.7%) and Veillonellaceae (35.6 ± 31.5%) were observed. In TC and DC, 
Lachnospiraceae (39.1 ± 5.1% and 47.1 ± 21.5%, respectively), Bacter-
oidaceae (23.7 ± 8.2% and 14.8 ± 9.7%, respectively), Ruminococcaceae 
(13.1 ± 3.1% and 6.6 ± 3.9%, respectively) and Enterobacteriaceae (5.5 
± 3.5% and 4.0 ± 1.8%, respectively) were detected. At T1, Enterobac-
teriaceae (53.6 ± 53.2%) and Veillonellaceae (45.2 ± 52.9%) remained 
stable in AC. In TC and DC, the proportions of Lachnospiraceae (42.7 ±
3.6% and 35.0 ± 4.2%, respectively), Bacteroidaceae (36.2 ± 12.1% and 
17.8 ± 11.3%, respectively), Ruminococcaceae (4.6 ± 0.1% and 7.6 ±
0.7%, respectively) and Enterobacteriaceae (3.7 ± 3.3% and 4.0 ± 0.8%, 
respectively) remained equally steady. At T2, Enterobacteriaceae (95.8 ±
0.8%) dominated the AC, followed by Veillonellaceae (1.6 ± 1.8%). In TC 
and DC, the relative abundance of most families stayed similar; Lach-
nospiraceae (41.8 ± 9.7% and 36.8 ± 2.9%, respectively), Bacteroidaceae 
(27.7 ± 18.6% and 22.4 ± 18.4%, respectively), Ruminococcaceae (15.3 
± 5.8% and 8.5 ± 5.6%, respectively) and Enterobacteriaceae (4.9 ±
3.7% and 4.18 ± 2.0%, respectively). 
In the study of Mateos et al. (2018), a decrease in proportion of 
Actinobacteria, Proteobacteria, Lachnospiraceae and Veillonellaceae was 
Fig. 5. (continued). 
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Fig. 6. Inversed Simpson diversity index means per colon region in the gastrointestinal tract (GIT) on genus level (mean ± SD). The colon regions stand for ascending 
colon (AC), transverse colon (TC) and descending colon (DC). T0 = after two weeks of stabilisation and before addition of mycotoxins; T1 = after one week of 
addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/kg food); T2 = after one week of addition of AFB1 (81.6 µg/kg food) and FB1 
(2000 µg/kg food), together with bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food). The asterisks represent the significant statistical difference in 
AC (p < 0.01) compared to TC and DC. 
Fig. 7. Microbial phyla present in the SHIME samples at T0, T1 and T2, in the AC, TC and DC of both repetitions. T0 = after two weeks of stabilisation and before 
addition of mycotoxins; T1 = after one week of addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/kg food); T2 = after one week of 
addition of AFB1 (81.6 µg/kg food) and FB1 (2000 µg/kg food), together with bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food); AC = ascending 
colon; TC = transverse colon; DC = descending colon. 
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observed in piglets after an exposure period to a combination of fumo-
nisin B1, B2 and B3 for 15 days. Oppositely to this study, these phyla and 
families remained stable in the SHIME model. Contrarily, to the study of 
Mateos et al. (2018), the SHIME system, which was a human model, was 
exposed to AFB1 and FB1 only for a period of 7 days. Interestingly, in a 
study performed by Ishikawa et al. (2017), a single oral AFB1 exposure 
increased the Lachnospiraceae family abundance in intestinal content of 
mice. However, the oral administration of AFB1 (63.4 µg/kg diet) to 
dairy cows during 5 days, did not affect the ruminal bacterial commu-
nity on phylum, nor on family level (Jiang et al., 2020). Furthermore, 
Fig. 8. Microbial families present in the SHIME samples at T0, T1 and T2, in the AC, TC and DC of both repetitions. T0 = after two weeks of stabilisation and before 
addition of mycotoxins; T1 = after one week of addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/kg food); T2 = after one week of 
addition of AFB1 (81.6 µg/kg food) and FB1 (2000 µg/kg food), together with bentonite clay (2.5 g/kg food) and fumonisin esterase (60 U/kg food); AC = ascending 
colon; TC = transverse colon; DC = descending colon. 
Fig. 9. Tree map of microbial genera present (≥1%) in the faecal inoculum and in the first repetition in %, at T0, T1 and T2, in the AC, TC and DC. T0 = after two 
weeks of stabilisation and before addition of mycotoxins; T1 = after one week of addition of aflatoxin B1 (AFB1) (81.6 µg/kg food) and fumonisin B1 (FB1) (2000 µg/ 
kg food); T2 = after one week of addition of AFB1 (81.6 µg/kg food) and FB1 (2000 µg/kg food), together with bentonite clay (2.5 g/kg food) and fumonisin esterase 
(60 U/kg food); AC = ascending colon; TC = transverse colon; DC = descending colon. 
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the addition of a bentonite clay did not affect the bacterial community 
either. 
It is difficult to analyse differences in results when comparing animal 
to human microbiota, as well as in vitro to in vivo studies, and this must 
be taken into consideration. Clearly, more studies are needed to analyse 
the impact of these mycotoxins on intestinal microbiota, especially on 
that of humans. 
4. Conclusions 
Two detoxifiers, namely an aflatoxin binder and a fumonisin 
esterase, proved their effectiveness in the simulated human (toddler) gut 
environment. The addition of the detoxifiers resulted in a significant 
decrease in aflatoxin B1 (AFB1) and fumonisin B1 (FB1) concentrations. 
Approximately 100% of AFB1 and FB1 was removed in the system after 
five days, and bound to bentonite or hydrolysed to non-toxic variants, 
respectively. Our study provided strong evidence that the fumonisin 
esterase is responsible for the full hydrolysis of FB; the concentration of 
the fully hydrolysed FB1 – which is far less toxic compared to the parent 
molecule – only increased after the addition of fumonisin esterase. 
Future studies should include monitoring the effect of detoxifiers on 
nutritional status, namely the long-term safety of the products. The in-
testinal short-chain fatty acid profile, in terms of the acetate/propio-
nate/butyrate ratio, resembled that of an infant. This confirmed the 
presence of healthy gut microbiota, which remained stable over the 
complete study period. The 16S metagenetic analysis gave further in-
sights into the specific bacterial composition of the colon regions. No 
obvious changes in composition of the microbial communities were 
observed, again a confirmation of a suitable, healthy study environment 
and first evidence for the possibility to use these two detoxifiers in 
humans. 
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tigation. Bernard Taminiau: Formal analysis. Caroline Douny: Formal 
analysis, Writing - review & editing. Marie-Louise Scippo: Writing - 
review & editing, Funding acquisition, Project administration. Dian 
Schatzmayr: Conceptualization, Resources. James Gathumbi: Funding 
acquisition, Project administration. Silvio Uhlig: Conceptualization, 
Writing - review & editing, Supervision, Funding acquisition, Project 
administration. Siska Croubels: Conceptualization, Writing - review & 
editing, Supervision, Funding acquisition, Project administration. 
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Delcenserie, V. (2020). A toddler SHIME® model to study microbiota of young 
children. FEMS Microbiology Letters, 367(16), fnaa135. https://doi.org/10.1093/ 
femsle/fnaa135. 
Bondue, P., Lebrun, S., Taminiau, B., Everaert, N., LaPointe, G., Hendrick, C., … 
Delcenserie, V. (2020). Effect of Bifidobacterium crudilactis and 3′-sialyllactose on 
the toddler microbiota using the SHIME® model. Food Research International, 138. 
https://doi.org/10.1016/j.foodres.2020.109755. 
CDC (2004). Outbreak of aflatoxin poisoning-eastern and central provinces, Kenya, 
January-July 2004. Morbidity and Mortality Weekly Report (MMWR) (Vol. 53). 
Cinquin, C., Le Blay, G., Fliss, I., & Lacroix, C. (2006). New three-stage in vitro model for 
infant colonic fermentation with immobilized fecal microbiota. FEMS Microbiology 
Ecology, 57(2), 324–336. https://doi.org/10.1111/j.1574-6941.2006.00117.x. 
Creppy, E. E. (2002). Update of survey, regulation and toxic effects of mycotoxins in 
Europe. Toxicology Letters, 127(1–3), 19–28. https://doi.org/10.1016/S0378-4274 
(01)00479-9. 
Cummings, J. H. (1981). Short chain fatty acids in the human colon. Gut, 22(9), 
763–779. https://doi.org/10.1136/gut.22.9.763. 
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., 
… Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut 
microbiome. Nature, 505(7484), 559–563. https://doi.org/10.1038/nature12820. 
De Baere, S., Goossens, J., Osselaere, A., Devreese, M., Vandenbroucke, V., De Backer, P., 
& Croubels, S. (2011). Quantitative determination of T-2 toxin, HT-2 toxin, 
deoxynivalenol and deepoxy-deoxynivalenol in animal body fluids using LC–MS/MS 
detection. Journal of Chromatography B, 879(24), 2403–2415. https://doi.org/ 
10.1016/j.jchromb.2011.06.036. 
Dell’Orto, V., Baldi, G., & Cheli, F. (2015). Mycotoxins in silage: checkpoints for effective 
management and control. World Mycotoxin Journal, 8(5), 603–617. https://doi.org/ 
10.3920/WMJ2014.1866. 
Demigne, C., Remesy, C., & Morand, C. (1999). Short chain fatty acids. In G. R. Gibson, & 
M. B. Roberfroid (Eds.), Colonic microbiota, nutrition and health (pp. 55–69). 
Dordrecht: Springer. https://doi.org/10.1007/978-94-017-1079-4.  
Douny, C., Dufourny, S., Brose, F., Verachtert, P., Rondia, P., Lebrun, S., … Scippo, M.-L. 
(2019). Development of an analytical method to detect short-chain fatty acids by 
SPME-GC–MS in samples coming from an in vitro gastrointestinal model. Journal of 
Chromatography B, 1124, 188–196. https://doi.org/10.1016/j.jchromb.2019.06.013. 
EC. (2013a). Commission implementing regulation (EU) No 1060/2013 of 29 October 
2013 concerning the authorisation of bentonite as a feed additive for all animal 
species. Official Journal of the European Union, 289, 33–37. 
EC (2013b). European Union Reference Laboratory Evaluation Report on the analytical 
methods submitted in connection with the application for authorisation of a feed 
additive according to regulation (EC) No 1831/2003. 
EC (2020). European Union Register of Feed Additives pursuant to Regulation (EC) No 
1831/2003. Annex I: List of additives. 
European Commission. (2002). Commission Decision of 12 August 2002 implementing 
Council Directive 96/23/EC concerning the performance of analytical methods and 
the interpretation of results. Official Journal of the European Communities, 221, 8–36. 
FAO (2004). Worldwide Regulations for mycotoxins in food and feed 2003. Food and 
Nutrition Paper No. 81. 
FAO (2020). The state of food security and nutrition in the world. 
FAO, IFAD, & WFP (2013). The state of food insecurity in the world. 
FEEDAP. (2011). Scientific Opinion on the safety and efficacy of bentonite (dioctahedral 
montmorillonite) as feed additive for all species. EFSA Journal, 9(2). https://doi.org/ 
10.2903/j.efsa.2011.2007. 
FEEDAP, Rychen, G., Aquilina, G., Azimonti, G., Bampidis, V., de Lourdes Bastos, M., … 
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